13F-HR filed by DIADEMA PARTNERS LP
DIADEMA PARTNERS LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 149 holding rows worth $791,347,834.
- Accession
- 0001892688-26-000119
- Filer
- CIK 2026172
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 149 entries on the cover page, a total value of $791,347,834 stated on the cover page (in dollars after the unit check, H1), rows summing to $791,347,834 with VALUE read as dollars as filed, 13F file number 028-25172. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,220,800 | $47,623,408 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 349,200 | $46,534,392 | dollars as filed | call |
| Bristol-Myers Squibb Company | 110122108 | COM | 600,000 | $34,572,000 | dollars as filed | call |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 252,400 | $33,634,824 | dollars as filed | put |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 52,989 | $28,711,030 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 139,218 | $26,072,747 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 163,644 | $21,598,038 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 493,664 | $19,104,797 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 330,600 | $19,049,172 | dollars as filed | put |
| BRIDGEBIO PHARMA INC | 10806XAJ1 | NOTE 1.750% 3/0 | 250,000 | $18,620,000 | dollars as filed | principal |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 206,300 | $17,937,785 | dollars as filed | call |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 312,846 | $17,901,048 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 441,808 | $17,234,930 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 149,700 | $17,166,099 | dollars as filed | call |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 100,000 | $15,672,000 | dollars as filed | put |
| UNIQURE NV | N90064101 | SHS | 299,000 | $13,771,940 | dollars as filed | put |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 350,500 | $13,673,005 | dollars as filed | put |
| BIOGEN INC COM | 09062X103 | Stock | 60,000 | $12,963,600 | dollars as filed | call |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 534,400 | $12,868,352 | dollars as filed | put |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 860,200 | $12,533,114 | dollars as filed | call |
| Eli Lilly and Company | 532457108 | COM | 10,000 | $11,994,300 | dollars as filed | put |
| INCYTE CORP COM | 45337C102 | Stock | 105,400 | $11,948,144 | dollars as filed | put |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 272,214 | $11,060,055 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 235,400 | $10,842,524 | dollars as filed | call |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 100,000 | $9,305,000 | dollars as filed | call |
| KODIAK SCIENCES INC | 50015M109 | COM | 218,117 | $8,497,838 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 254,863 | $8,091,900 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 329,300 | $7,929,544 | dollars as filed | call |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 50,000 | $7,836,000 | dollars as filed | call |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 696,300 | $7,708,041 | dollars as filed | call |
| KODIAK SCIENCES INC | 50015M109 | COM | 196,700 | $7,663,432 | dollars as filed | call |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 571,107 | $7,595,723 | dollars as filed | |
| MODERNA INC | 60770K107 | COM | 100,000 | $7,003,000 | dollars as filed | put |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 200,000 | $6,934,000 | dollars as filed | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 223,810 | $6,900,062 | dollars as filed | |
| HIMS & HERS HEALTH INC | 433000106 | COM CL A | 193,700 | $6,715,579 | dollars as filed | put |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 633,800 | $5,945,044 | dollars as filed | call |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 400,000 | $5,904,000 | dollars as filed | call |
| KODIAK SCIENCES INC | 50015M109 | COM | 146,900 | $5,723,224 | dollars as filed | put |
| ALUMIS INC | 022307102 | COM | 200,000 | $5,628,000 | dollars as filed | call |
| ROYALTY PHARMA PLC | G7709Q104 | SHS CLASS A | 100,000 | $5,607,000 | dollars as filed | call |
| Johnson & Johnson | 478160104 | COM | 22,000 | $5,587,340 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 502,500 | $5,562,675 | dollars as filed | put |
| BIOAGE LABS INC COM | 09077V100 | Stock | 200,100 | $4,904,451 | dollars as filed | call |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 100,000 | $4,809,442 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 317,000 | $4,716,960 | dollars as filed | call |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 307,000 | $4,466,850 | dollars as filed | call |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 294,811 | $4,404,476 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 230,677 | $4,315,967 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 75,700 | $4,158,958 | dollars as filed | call |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 170,100 | $4,116,420 | dollars as filed | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 124,000 | $3,822,920 | dollars as filed | call |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 792,600 | $3,717,294 | dollars as filed | call |
| ZYMEWORKS INC | 98985Y108 | COM | 142,132 | $3,715,330 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 10,000 | $3,621,200 | dollars as filed | call |
| BIOAGE LABS INC COM | 09077V100 | Stock | 146,334 | $3,586,646 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 522,619 | $3,559,035 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 200,000 | $3,384,000 | dollars as filed | call |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 86,000 | $3,200,060 | dollars as filed | put |
| VAXCYTE INC COM | 92243G108 | Stock | 53,100 | $3,086,703 | dollars as filed | call |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 121,539 | $2,948,536 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 200,000 | $2,914,000 | dollars as filed | put |
| VAXCYTE INC COM | 92243G108 | Stock | 48,900 | $2,842,557 | dollars as filed | put |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 301,264 | $2,825,856 | dollars as filed | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 67,512 | $2,770,017 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 740,786 | $2,725,718 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 55,900 | $2,679,846 | dollars as filed | put |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 27,799 | $2,645,631 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 45,071 | $2,619,977 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 30,000 | $2,555,700 | dollars as filed | put |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 361,367 | $2,500,660 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 57,608 | $2,471,959 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 50,000 | $2,145,500 | dollars as filed | put |
| CELCUITY INC | 15102K100 | COM | 20,000 | $2,092,400 | dollars as filed | call |
| ANNEXON INC | 03589W102 | COM | 353,200 | $2,016,772 | dollars as filed | call |
| SEPTERNA INC COM | 81734D104 | Stock | 59,700 | $1,999,353 | dollars as filed | put |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 133,400 | $1,992,996 | dollars as filed | call |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 119,733 | $1,962,424 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 462,724 | $1,961,950 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 78,391 | $1,897,062 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 50,900 | $1,893,989 | dollars as filed | call |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 100,000 | $1,837,000 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 374,403 | $1,729,742 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 926,016 | $1,722,390 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 200,000 | $1,674,000 | dollars as filed | call |
| SPRUCE BIOSCIENCES INC | 85209E208 | COM NEW | 30,000 | $1,620,000 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 303,025 | $1,545,428 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 48,369 | $1,526,526 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 56,347 | $1,520,242 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 106,300 | $1,520,090 | dollars as filed | call |
| SELLAS LIFE SCIENCES GROUP I | 81642T209 | COM NEW | 100,000 | $1,476,000 | dollars as filed | put |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 149,482 | $1,463,429 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 413,642 | $1,447,747 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 303,676 | $1,424,240 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 129,950 | $1,409,958 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 200,000 | $1,388,000 | dollars as filed | call |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 15,000 | $1,331,700 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 200,000 | $1,322,000 | dollars as filed | |
| CORMEDIX INC COM | 21900C308 | Stock | 167,500 | $1,314,875 | dollars as filed | put |
| EDITAS MEDICINE INC | 28106W103 | COM | 400,000 | $1,296,000 | dollars as filed | call |
| EQUILLIUM INC | 29446K106 | COM | 400,282 | $1,280,902 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 388,200 | $1,168,482 | dollars as filed | call |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 132,746 | $1,051,348 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 29,321 | $1,013,920 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 26,864 | $978,118 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 87,057 | $907,134 | dollars as filed | |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 214,600 | $892,736 | dollars as filed | call |
| RIGEL PHARMACEUTICALS INC | 766559702 | COMMON STOCK | 22,816 | $892,562 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 60,000 | $874,200 | dollars as filed | |
| PRECIGEN INC | 74017N105 | COM | 135,293 | $771,170 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 15,451 | $726,815 | dollars as filed | |
| PELTHOS THERAPEUTICS INC | 171126204 | COM SHS | 24,773 | $700,085 | dollars as filed | |
| PEPGEN INC COM | 713317105 | Stock | 373,284 | $671,911 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 100,000 | $661,000 | dollars as filed | call |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 150,000 | $525,000 | dollars as filed | call |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 7,300 | $518,665 | dollars as filed | call |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 10,000 | $507,500 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | G23549101 | SHS | 196,985 | $468,824 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 146,637 | $447,243 | dollars as filed | |
| Elicio Therapeutics Inc Com | 28657F103 | LST Equity Option | 112,100 | $438,311 | dollars as filed | call |
| Elicio Therapeutics Inc Com | 28657F103 | LST Equity Option | 100,000 | $391,000 | dollars as filed | put |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 138,341 | $384,588 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 66,908 | $326,511 | dollars as filed | |
| AYTU BIOPHARMA INC | 054754858 | COM | 148,546 | $319,374 | dollars as filed | |
| OCUGEN INC | 67577C105 | COMMON STOCK | 200,000 | $306,000 | dollars as filed | |
| INOVIO PHARMACEUTICALS I | 45773H409 | COMMON STOCK | 275,200 | $302,720 | dollars as filed | call |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 7,137 | $262,642 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 102,701 | $214,645 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 458,723 | $195,783 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 153,563 | $158,170 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 27,516 | $157,116 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 1,630 | $150,922 | dollars as filed | |
| LAKELAND INDS INC | 511795106 | COM | 14,108 | $150,815 | dollars as filed | |
| UPSTREAM BIO INC | 91678A107 | COMMON STOCK | 19,093 | $132,124 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 8,368 | $113,052 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 9,021 | $102,479 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 3,621 | $79,771 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 16,003 | $68,173 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 23,260 | $41,170 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 4,860 | $38,929 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 44,907 | $36,029 | dollars as filed | |
| TVARDI THERAPEUTICS INC | 140755307 | COM | 16,607 | $31,553 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 57,700 | $13,040 | dollars as filed | call |
| NEXTCURE INC | 65343E207 | COM NEW | 7,742 | $12,387 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 12,500 | $7,460 | dollars as filed | put |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 500 | $6,755 | dollars as filed | call |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,046 | $3,174 | dollars as filed | put |
| ERASCA INC COM | 29479A108 | Stock | 100 | $1,832 | dollars as filed | call |
| CUE BIOPHARMA INC | 22978P205 | COM | 6 | $6 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001892688-26-000119 | this filing | 2026-08-14 | acceptance time not in the bulk data set |